Article Information
History
- February 17, 2021.
Article Versions
- Version 1 (February 16, 2021 - 15:00).
- Version 2 (February 16, 2021 - 18:00).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maxence Le Vasseur1,
- Jonathan R. Friedman1,2,
- Marco Jost3,4,5,
- Jiawei Xu1,
- Justin Yamada1,
- Martin Kampmann3,4,6,7,
- Max A. Horlbeck3,4,
- Michelle R. Salemi8,
- Brett S. Phinney8,
- Jonathan S. Weissman3,4,9,10 and
- Jodi Nunnari1,*
- 1Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, CA, 95616, USA
- 2Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
- 3Department of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, CA, 94158, USA
- 4Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, CA, 94158, USA
- 5Department of Microbiology and Immunology, University of California at San Francisco, San Francisco, CA, 94158, USA
- 6Institute for Neurodegenerative Diseases and Department of Biochemistry and Biophysics, University of California at San Francisco, San Francisco, CA, 94158, USA
- 7Chan-Zuckerberg Biohub, San Francisco, CA, 94158, USA
- 8Proteomics Core Facility, University of California, Davis, CA 95616, USA
- 9Whitehead Institute, Cambridge, MA, USA
- 10Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
- ↵*Corresponding author email: jmnunnari{at}ucdavis.edu
Posted February 17, 2021.
Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells
